Quercetin, a natural dietary flavonoid, acts as a chemopreventive agent against prostate cancer in an in vivo model by inhibiting the EGFR signaling pathway

2014 ◽  
Vol 5 (10) ◽  
pp. 2632-2645 ◽  
Author(s):  
A. B. Firdous ◽  
G. Sharmila ◽  
S. Balakrishnan ◽  
P. RajaSingh ◽  
S. Suganya ◽  
...  

Prostate cancer incidence and mortality rates have increased over the past years.

2014 ◽  
Vol 33 (4) ◽  
pp. 718-726 ◽  
Author(s):  
G. Sharmila ◽  
F.A. Bhat ◽  
R. Arunkumar ◽  
P. Elumalai ◽  
P. Raja Singh ◽  
...  

2011 ◽  
Vol 2011 ◽  
pp. 1-10 ◽  
Author(s):  
Anselm J. M. Hennis ◽  
Ian R. Hambleton ◽  
Suh-Yuh Wu ◽  
Desiree H.-A. Skeete ◽  
Barbara Nemesure ◽  
...  

We describe prostate cancer incidence and mortality in Barbados, West Indies. We ascertained all histologically confirmed cases of prostate cancer during the period July 2002 to December 2008 and reviewed each death registration citing prostate cancer over a 14-year period commencing January 1995. There were 1101 new cases for an incidence rate of 160.4 (95% Confidence Interval: 151.0–170.2) per 100,000 standardized to the US population. Comparable rates in African-American and White American men were 248.2 (95% CI: 246.0–250.5) and 158.0 (95% CI: 157.5–158.6) per 100,000, respectively. Prostate cancer mortality rates in Barbados ranged from 63.2 to 101.6 per 100,000, compared to 51.1 to 78.8 per 100,000 among African Americans. Prostate cancer risks are lower in Caribbean-origin populations than previously believed, while mortality rates appeared to be higher than reported in African-American men. Studies in Caribbean populations may assist understanding of disparities among African-origin populations with shared heredity.


Bone ◽  
2000 ◽  
Vol 27 (4) ◽  
pp. 42
Author(s):  
M Howard ◽  
J Fisher ◽  
J Schmitt ◽  
G Risbridger ◽  
P Choong

Cells ◽  
2021 ◽  
Vol 10 (9) ◽  
pp. 2387
Author(s):  
Amandine Rambur ◽  
Marine Vialat ◽  
Claude Beaudoin ◽  
Corinne Lours-Calet ◽  
Jean-Marc Lobaccaro ◽  
...  

Prostate cancer is the most common cancer in aging men. Despite recent progress, there are still few effective treatments to cure its aggressive and metastatic stages. A better understanding of the molecular mechanisms driving disease initiation and progression appears essential to support the development of more efficient therapies and improve patient care. To do so, multiple research models, such as cell culture and mouse models, have been developed over the years and have improved our comprehension of the biology of the disease. Recently, a new model has been added with the use of the Drosophila accessory gland. With a high level of conservation of major signaling pathways implicated in human disease, this functional equivalent of the prostate represents a powerful, inexpensive, and rapid in vivo model to study epithelial carcinogenesis. The purpose of this review is to quickly overview the existing prostate cancer models, including their strengths and limitations. In particular, we discuss how the Drosophila accessory gland can be integrated as a convenient complementary model by bringing new understanding in the mechanisms driving prostate epithelial tumorigenesis, from initiation to metastatic formation.


Sign in / Sign up

Export Citation Format

Share Document